Tirzepatide Providers in Delaware
0 providers offering Tirzepatide in Delaware
About Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist marketed as Mounjaro (for diabetes) and Zepbound (for weight loss). It is the first medication to activate both incretin hormone receptors simultaneously, leading to superior weight loss results compared to GLP-1-only medications. Clinical trials showed average weight loss of up to 22.5% of body weight.
Learn more about TirzepatideNo Tirzepatide providers in Delaware yet
Try browsing all providers in Delaware or check telehealth options.
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.